Prognostic factors for resected non ‐small cell lung cancer in patients with type 2 diabetes mellitus

ConclusionsProper glycemic control (glycated hemoglobin A1c <7%) is recommended for diabetic patients undergoing lung cancer operations. Further studies are required to elucidate associations between type 2 diabetes mellitus and antineoplastic effects of statins and to evaluate statins as a novel adjuvant treatment for lung cancer.

Source: Journal of Surgical Oncology - February 6, 2018 Category: Cancer & Oncology Authors: Woo Sik Yu, Chang Young Lee, Seong Yong Park, Jee Won Suh, Kyoung Shik Narm, Dae Joon Kim, Kyung Young Chung, Jin Gu Lee Tags: RESEARCH ARTICLE Source Type: research